Merit Financial Group, LLC Astrazeneca PLC Transaction History
Merit Financial Group, LLC
- $6.49 Billion
- Q1 2025
A detailed history of Merit Financial Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Merit Financial Group, LLC holds 23,583 shares of AZN stock, worth $1.72 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
23,583
Previous 8,840
166.78%
Holding current value
$1.72 Million
Previous $579,000
199.31%
% of portfolio
0.03%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.16 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.96 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.59 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.32 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.28 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $226B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...